RCM Technologies, Inc. Announces Fourth Quarter And Fiscal Year 2025 Results

PENNSAUKEN, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NASDAQGM:RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty healthcare, and information technology services, today announced financial results for the fourteen and fifty-three weeks ended January 3, 2026.

RCM Technologies reported revenue of $86.5 million for the fourteen weeks ended January 3, 2026 (the current quarter), an increase of 12.4% compared to $76.9 million for the thirteen weeks ended December 28, 2024 (the comparable prior quarter). Gross profit was $24.3 million for the current quarter, a 12.6% increase compared to $21.6 million for the comparable prior quarter. The Company reported GAAP net income of $6.1 million, or $0.80 per diluted share, for the current quarter, compared with $2.9 million, or $0.37 per diluted share, for the comparable prior quarter. The Company reported adjusted EBITDA (non-GAAP) of $9.3 million for the current quarter, as compared to $6.3 million for the comparable prior quarter, an increase of 49.0%. The Company experienced $0.77 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.49 for the comparable prior quarter.

RCM Technologies reported revenue of $319.4 million for the fifty-three weeks ended January 3, 2026 (the current year), an increase of 14.7% compared to $278.4 million for the fifty-two weeks ended December 28, 2024 (the comparable prior year). Gross profit was $87.9 million for the current year, a 10.2% increase compared to $79.8 million for the comparable prior year. The Company reported GAAP net income of $16.3 million, or $2.14 per diluted share, for the current year compared to $13.3 million, or $1.68 per diluted share, for the comparable prior year. The Company reported adjusted EBITDA (non-GAAP) of $30.7 million for the current year as compared to $25.9 million for the comparable prior year, an increase of 18.9%. The Company reported $2.50 of adjusted net income per diluted share (non-GAAP) for the current year as compared to $2.03 for the comparable prior year.

The Company will not be holding a conference call to discuss these results. Additional information can be found in the Company's Form 10-K.

About RCM

RCM Technologies (NASDAQGM:RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company's actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should," "are confident" or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow

RCM Technologies, Inc. Condensed Consolidated Statements of Operations (Unaudited) (In thousands, except share and per share amounts)
	Fourteen and Thirteen Weeks Ended
	January 3, 2026		December 28, 2024
Revenue	$86,476		$76,912
Cost of services	62,198		55,343
Gross profit	24,278		21,569
Selling, general and administrative	15,753		16,025
Depreciation and amortization of property and equipment	554		407
Impairment of intangible assets	-		547
Potential stock issuance and financing transactions	-		64
Remeasurement of contingent consideration	-		(1,759	)
Operating income	7,971		6,285
Other expense, net	780		516
Income before income taxes	7,191		5,769
Income tax expense	1,087		2,902
Net income	$6,104		$2,867
Diluted net earnings per share data	$0.80		$0.37
Diluted weighted average shares outstanding	7,587,448		7,733,142

	Fifty-Three and Fifty-Two Weeks Ended
	January 3, 2026		December 28, 2024
Revenue	$319,404		$278,380
Cost of services	231,461		198,602
Gross profit	87,943		79,778
Selling, general and administrative	60,932		56,787
Depreciation and amortization of property and equipment	1,918		1,419
Amortization of acquired intangible assets	-		136
Impairment of intangible assets	-		547
Potential stock issuance and financing transactions	-		323
Remeasurement of contingent consideration	-		(1,759	)
Operating income	25,093		22,325
Other expense, net	3,021		2,135
Income before income taxes	22,072		20,190
Income tax expense	5,738		6,863
Net income	$16,334		$13,327
Diluted net earnings per share data	$2.14		$1.68
Diluted weighted average shares outstanding	7,635,740		7,939,381

RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Unaudited) (In thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures ("Adjusted operating income," "EBITDA," "Adjusted EBITDA," "Adjusted net income" and "Adjusted diluted net earnings per share") are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors' overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance. In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company's GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share for the fourteen and fifty-three weeks ended January 3, 2026, and the thirteen and fifty-two weeks ended December 28, 2024. 

	Fourteen and Thirteen Weeks Ended				Fifty-Three and Fifty-Two Weeks Ended
	January 3, 2026		December 28, 2024		January 3, 2026		December 28, 2024
GAAP operating income	$7,971		$6,285		$25,093		$22,325
Adjustments
Remeasurement of contingent consideration	-		(1,759	)	-		(1,759	)
Equity compensation	793		710		3,732		2,864
Potential stock issuance and financing transaction	-		64		-		323
Impairment of intangible assets	-		547		-		547
Adjusted operating income (non-GAAP)	$8,764		$5,847		$28,825		$24,300
GAAP net income	$6,104		$2,867		$16,334		$13,327
Income tax expense	1,087		2,902		5,738		6,863
Interest expense, net	784		664		2,669		2,215
Depreciation of property and equipment	554		407		1,918		1,419
Amortization of acquired intangible assets	-		-		-		136
EBITDA (non-GAAP)	$8,529		$6,840		$26,659		$23,960
Adjustments
Remeasurement of contingent consideration	-		(1,759	)	-		(1,759	)
(Gain) loss on foreign currency transactions	(4	)	(148	)	352		(80	)
Equity compensation	793		710		3,732		2,864
Potential stock issuance and financing transaction	-		64		-		323
Impairment of intangible assets	-		547		-		547
Adjusted EBITDA (non-GAAP)	$9,318		$6,254		$30,743		$25,855

RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Continued) (Unaudited) (In thousands, except per share amounts)
	Fourteen and Thirteen Weeks Ended						Fifty-Three and Fifty-Two Weeks Ended
	January 3, 2026			December 28, 2024			January 3, 2026			December 28, 2024
GAAP net income	$6,104			$2,867			$16,334			$13,327
Adjustments
Remeasurement of contingent consideration		-			(1,759	)		-			(1,759	)
(Gain) loss on foreign currency transactions		(4	)		(148	)		352			(80	)
Equity compensation		793			710			3,732			2,864
Potential stock issuance and financing transaction		-			64			-			323
Impairment of intangible assets		-			547			-			547
Tax impact from normalized rate		(1,068	)		1,503			(1,324	)		900
Adjusted net income (non-GAAP)	$5,825			$3,784			$19,094			$16,122
GAAP diluted net earnings per share	$0.80			$0.37			$2.14			$1.68
Adjustments
Remeasurement of contingent consideration		-		($0.22		)		-		($0.22		)
(Gain) loss on foreign currency transactions	($0.00		)	($0.02		)	$0.04			($0.01		)
Equity compensation	$0.11			$0.09			$0.49			$0.36
Potential stock issuance and financing transaction		-		$0.01				-		$0.04
Impairment of intangible assets		-		$0.07				-		$0.07
Tax impact from normalized rate(a)	($0.14		)	$0.19			($0.17		)	($0.11		)
Adjusted diluted net earnings per share (non-GAAP)	$0.77			$0.49			$2.50			$2.03

(a)

Amount reflects an adjustment to income tax expense applied to non-GAAP adjusted consolidated taxable income. The Company used an estimated effective income tax rate of 27.0% for both periods presented, approximating the Company's federal USA income tax rate plus the tax-affected rate for states and Puerto Rico.

RCM Technologies, Inc. Summary of Selected Income Statement Data (Unaudited) (In thousands)
	Fourteen Weeks Ended January 3, 2026
	Specialty Health Care			Engineering			Life Sciences, Data and Solutions			Consolidated
Revenue	$47,999			$30,404			$8,073			$86,476
Cost of services		34,067			22,608			5,523			62,198
Gross profit	$13,932			$7,796			$2,550			$24,278
Gross profit margin		29.0	%		25.6	%		31.6	%		28.1	%

	Thirteen Weeks Ended December 28, 2024
	Specialty Health Care			Engineering			Life Sciences, Data and Solutions			Consolidated
Revenue	$41,011			$26,279			$9,622			$76,912
Cost of services		28,474			21,098			5,771			55,343
Gross profit	$12,537			$5,181			$3,851			$21,569
Gross profit margin		30.6	%		19.7	%		40.0	%		28.0	%

	Fifty-Three Weeks Ended January 3, 2026
	Specialty Health Care			Engineering			Life Sciences, Data and Solutions			Consolidated
Revenue	$164,104			$120,486			$34,814			$319,404
Cost of services		116,702			93,104			21,655			231,461
Gross profit	$47,402			$27,382			$13,159			$87,943
Gross profit margin		28.9	%		22.7	%		37.8	%		27.5	%

	Fifty-Two Weeks Ended December 28, 2024
	Specialty Health Care			Engineering			Life Sciences, Data and Solutions			Consolidated
Revenue	$142,679			$96,459			$39,242			$278,380
Cost of services		100,146			73,916			24,540			198,602
Gross profit	$42,533			$22,543			$14,702			$79,778
Gross profit margin		29.8	%		23.4	%		37.5	%		28.7	%

RCM Technologies, Inc. Consolidated Balance Sheets (Unaudited) (In thousands, except share amounts)
	January 3,			December 28,
	2026			2024
Current assets:
Cash and cash equivalents	$2,922			$4,729
Accounts receivable, net of provision for credit losses of $1,229 and $1,570 at January 3, 2026 and December 28, 2024, respectively		81,243			77,960
Transit accounts receivable		8,017			7,315
Prepaid expenses and other current assets		7,704			7,034
Total current assets		99,886			97,038
Property and equipment, net		7,265			7,368
Other assets:
Deposits		261			230
Deferred tax assets, foreign		6			120
Goodwill		22,147			22,147
Operating right of use asset		4,832			5,174
Total other assets		27,246			27,671
Total assets	$134,397			$132,077

Current liabilities:
Accounts payable and accrued expenses	$9,649		$13,369
Transit accounts payable	16,247		23,870
Accrued payroll and related costs	10,784		9,929
Finance lease payable	843		698
Income taxes payable	391		346
Operating right of use liability	1,209		1,046
Contingent consideration from acquisitions	-		212
Deferred revenue	14,761		4,163
Total current liabilities	53,884		53,633
Deferred income taxes, net, domestic	5,673		4,526
Finance lease payable, net of current position	380		1,112
Operating right of use liability, net of current position	3,813		4,355
Borrowings under line of credit	24,673		34,967
Total liabilities	88,423		98,593
Contingencies (note 16) and Commitments (note 18)
Stockholders' equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized;
no shares issued or outstanding	-		-
Common stock, $0.05 par value; 40,000,000 shares authorized;
18,004,241 shares issued and 7,351,400 shares outstanding at January 3, 2026 and 17,838,372 shares issued and 7,602,113 shares outstanding at December 28, 2024	900		890
Additional paid-in capital	122,244		118,845
Accumulated other comprehensive loss	(2,814	)	(2,920	)
Accumulated deficit	10,396		(5,938	)
Treasury stock, 10,652,841 shares at January 3, 2026 and 10,236,259 shares at December 28, 2024	(84,752	)	(77,393	)
Stockholders' equity	45,974		33,484
Total liabilities and stockholders' equity	$134,397		$132,077

RCM Technologies, Inc. Condensed Consolidated Statements of Cash Flows (Unaudited) (In thousands)
	Fourteen and Thirteen Weeks Ended
	January 3, 2026		December 28, 2024
Net income	$6,104		$2,867
Adjustments to reconcile net income to cash used in operating activities	3,911		2,693
Changes in operating assets and liabilities:
Accounts receivable	1,097		(2,064	)
Prepaid expenses and other current assets	(3,541	)	(1,917	)
Net of transit accounts receivable and payable	1,005		(5,345	)
Accounts payable and accrued expenses	(3,415	)	1,861
Accrued payroll and related costs	(2,012	)	(1,698	)
Operating lease liabilities	(396	)	(280	)
Income taxes payable	144		140
Deferred revenue	8,530		2,121
Deposits	18		(15	)
Total adjustments	5,341		(4,504	)
Net cash provided by (used in) operating activities	$11,445		($1,637	)
Net cash used in investing activities	(197	)	(983	)
Net cash (used in) provided by financing activities	(9,567	)	4,307
Effect of exchange rate changes on cash and cash equivalents	(68	)	(114	)
Increase in cash and cash equivalents	$1,613		$1,573

	Fifty-Three and Fifty-Two Weeks Ended
	January 3, 2026			December 28, 2024
Net income	$16,334			$13,327
Adjustments to reconcile net income to cash used in operating activities		8,991			6,893
Changes in operating assets and liabilities:
Accounts receivable		(4,152	)		(7,271	)
Prepaid expenses and other current assets		(676	)		(2,392	)
Net of transit accounts receivable and payable		(8,325	)		(5,656	)
Accounts payable and accrued expenses		(3,484	)		1,101
Accrued payroll and related costs		848			(1,265	)
Operating lease liabilities		(1,205	)		(966	)
Income taxes payable		36			34
Deferred revenue		10,628			2,282
Deposits		(30	)		83
Total adjustments		2,631			(7,157	)
Net cash provided by operating activities		18,965			6,170
Net cash used in investing activities		(1,595	)		(2,572	)
Net cash used in financing activities		(19,038	)		(4,828	)
Effect of exchange rate changes on cash and cash equivalents		(139	)		(325	)
Decrease in cash and cash equivalents	($1,807		)	($1,555		)

RCM Technologies, Inc.	Tel: 856.356.4500	Corporate Contacts:
2500 McClellan Avenue	[email protected]	Bradley S. Vizi
Pennsauken, NJ 08109	www.rcmt.com	Executive Chairman
		Kevin D. Miller
		Chief Financial Officer